Literature DB >> 33245394

AAV delivery of shRNA against IRS1 in GABAergic neurons in rat hippocampus impairs spatial memory in females and male rats.

Sandra Sánchez-Sarasúa1, Alberto Ribes-Navarro1,2, María Teresa Beltrán-Bretones1, Ana María Sánchez-Pérez3.   

Abstract

Brain insulin resistance is a major factor leading to impaired cognitive function and it is considered as the onset of Alzheimer´s disease. Insulin resistance is intimately linked to inflammatory conditions, many studies have revealed how pro-inflammatory cytokines lead to insulin resistance, by inhibiting IRS1 function. Thus, the dysfunction of insulin signaling is concomitant with inflammatory biomarkers. However, the specific effect of IRS1 impaired function in otherwise healthy brain has not been dissected out. So, we decided in our study, to study the specific role of IRS1 in the hippocampus, in the absence of comorbidities. To that end, shRNA against rat and human IRS1 was designed and tested in cultured HEK cells to evaluate mRNA levels and specificity. The best candidate sequence was encapsulated in an AAV vector (strain DJ8) under the control of the cytomegalovirus promoter and together with the green fluorescent protein gene as a reporter. AAV-CMV-shIRS1-EGFP and control AAV-CMV-EGFP were inoculated into the dorsal hippocampus of female and male Wistar rats. One month later, animals undertook a battery of behavioral paradigms evaluating spatial and social memory and anxiety. Our results suggest that females displayed increased susceptibility to AAV-shIRS1 in the novel recognition object paradigm; whereas both females and males show impaired performance in the T maze when infected with AAV-shIRS1 compared to control. Anxiety parameters were not affected by AAV-shIRS1 infection. We observed specific fluorescence within the hilum of the dentate gyrus, in immuno-characterized parvalbumin and somatostatin neurons. AAV DJ8 did not enter astrocytes. Intense green fibers were found in the fornix, mammillary bodies, and in the medial septum indicating that hippocampal efferent had been efficiently targeted by the AAV DJ8 infection. We observed that AAV-shIRS1 reduced significantly synaptophysin labeling in hippocampal-septal projections compared to controls. These results support that, small alterations in the insulin/IGF1 pathway in specific hippocampal circuitries can underlie alterations in synaptic plasticity and affect behavior, in the absence of inflammatory conditions.

Entities:  

Keywords:  Hippocampal dentate gyrus; IRS2; Immunofluorescence; Insulin resistance; Social memory; Synaptic plasticity; Synaptophysin

Year:  2020        PMID: 33245394     DOI: 10.1007/s00429-020-02155-x

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  62 in total

1.  Septal GABAergic and hippocampal cholinergic systems interact in the modulation of anxiety.

Authors:  A Degroot; D Treit
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

2.  Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests.

Authors:  Aldemar Degroot; Dallas Treit
Journal:  Brain Res       Date:  2002-09-13       Impact factor: 3.252

Review 3.  Insulin resistance in Alzheimer's disease.

Authors:  Kelly T Dineley; Jordan B Jahrling; Larry Denner
Journal:  Neurobiol Dis       Date:  2014-09-16       Impact factor: 5.996

Review 4.  Insulin, cognition, and dementia.

Authors:  Brenna Cholerton; Laura D Baker; Suzanne Craft
Journal:  Eur J Pharmacol       Date:  2013-09-23       Impact factor: 4.432

5.  GLUT4 Mobilization Supports Energetic Demands of Active Synapses.

Authors:  Ghazaleh Ashrafi; Zhuhao Wu; Ryan J Farrell; Timothy A Ryan
Journal:  Neuron       Date:  2017-01-19       Impact factor: 17.173

6.  Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action.

Authors:  Vincent Aguirre; Eric D Werner; Jodel Giraud; Yong Hee Lee; Steve E Shoelson; Morris F White
Journal:  J Biol Chem       Date:  2001-10-17       Impact factor: 5.157

7.  Insulinlike growth factor-1, insulinlike growth factor binding protein-1, and cognitive function in older men and women.

Authors:  Wael K Al-Delaimy; Denise von Muhlen; Elizabeth Barrett-Connor
Journal:  J Am Geriatr Soc       Date:  2009-06-08       Impact factor: 5.562

Review 8.  Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2.

Authors:  K D Copps; M F White
Journal:  Diabetologia       Date:  2012-08-08       Impact factor: 10.122

9.  Reduction of insulin signalling pathway IRS-1/IRS-2/AKT/mTOR and decrease of epithelial cell proliferation in the prostate of glucocorticoid-treated rats.

Authors:  Maitê M Costa; Natália M Violato; Sebastião R Taboga; Rejane M Góes; José R Bosqueiro
Journal:  Int J Exp Pathol       Date:  2012-06       Impact factor: 1.925

Review 10.  Thalamic pathology and memory loss in early Alzheimer's disease: moving the focus from the medial temporal lobe to Papez circuit.

Authors:  John P Aggleton; Agathe Pralus; Andrew J D Nelson; Michael Hornberger
Journal:  Brain       Date:  2016-04-28       Impact factor: 13.501

View more
  3 in total

1.  Sirt1 protects against hippocampal atrophy and its induced cognitive impairment in middle-aged mice.

Authors:  Zuhao Sun; Shuang Zhao; Xinjun Suo; Yan Dou
Journal:  BMC Neurosci       Date:  2022-06-06       Impact factor: 3.264

Review 2.  Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives.

Authors:  Ana Fajardo-Serrano; Alberto J Rico; Elvira Roda; Adriana Honrubia; Sandra Arrieta; Goiaz Ariznabarreta; Julia Chocarro; Elena Lorenzo-Ramos; Alvaro Pejenaute; Alfonso Vázquez; José Luis Lanciego
Journal:  Biomedicines       Date:  2022-03-23

3.  Insufficiency of ventral hippocampus to medial prefrontal cortex transmission explains antidepressant non-response.

Authors:  Mariusz Papp; Piotr Gruca; Magdalena Lason; Ewa Litwa; Wojciech Solecki; Paul Willner
Journal:  J Psychopharmacol       Date:  2021-10-07       Impact factor: 4.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.